Clusterin in Stool: A New Biomarker for Colon Cancer Screening?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Gastroenterology

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajg.2009.412PMID 19623170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Colorectal cancer screening].

  2010cited by this paper
• Multiple roles for Pur-α in cellular and viral regulation

  2009cited by this paper
• Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression

  2009cited by this paper
• Endoscopic Variceal Band Ligation

  2009cited by this paper
• The expression and the nuclear activity of the caretaker gene ku86 are modulated by somatostatin.

  2009cited by this paper
• Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * †

  2008cited by this paper
• Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps.

  2008cited by this paper
• Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer

  2008cited by this paper
• StAR: a simple tool for the statistical comparison of ROC curves

  2008cited by this paper
• Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review

  2007cited by this paper
• The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening.

  2007cited by this paper
• The multidisciplinary management of gastrointestinal cancer

  2007cited by this paper
• Understanding diagnostic tests 3: receiver operating characteristic curves

  2007cited by this paper
• Stool test for colorectal cancer screening: what is going on?

  2007cited by this paper
• Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

  2006cited by this paper
• Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer.

  2006cited by this paper
• Noninvasive Testing for Colorectal Cancer: A Review

  2005cited by this paper
• Modulation of different clusterin isoforms in human colon tumorigenesis

  2004cited by this paper
• Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

  2003cited by this paper
• Colorectal cancer screening: scientific review.

  2003cited by this paper
• Synthesis and Functional Analyses of Nuclear Clusterin, a Cell Death Protein*

  2003cited by this paper
• AMERICAN GASTROENTEROLOGICAL ASSOCIATION Colorectal Cancer Screening and Surveillance : Clinical Guidelines and Rationale — Update Based on New Evidence

  2003cited by this paper
• Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction.

  2002cited by this paper
• Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

  2001cited by this paper
• An antigen capture assay for the measurement of serum clusterin concentrations.

  2001cited by this paper
• Overexpression of clusterin in human breast carcinoma.

  2000cited by this paper
• Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death.

  2000cited by this paper

• Detection of Biomarker Clusterin in SERS Immunoassays on Al Foil After Substrate Selection and Assay Optimization with Fluorescently Labeled Antibodies

  2025cites this paper
• Clusterin: a marker and mediator of chemoresistance in colorectal cancer

  2024cites this paper
• Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis

  2022cites this paper
• Clusterin mRNA silencing reduces cell proliferation, inhibits cell migration, and increases CCL5 expression in SW480, SW620, and Caco2 cells

  2022cites this paper
• Immunohistochemical expression of clusterin in colorectal carcinoma

  2021cites this paper
• Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses

  2020cites this paper
• High Clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.

  2019cites this paper
• Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1

  2019cites this paper
• Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease

  2019cites this paper
• Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.

  2019cites this paper
• MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma

  2018cites this paper
• Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level

  2018cites this paper
• Introduction to Clinical Diagnosis

  2018cites this paper
• Clusterin and neuropilin-2 as potential biomarkers of tumor progression in benzo[a]pyrene-transformed 16HBE cells xenografted nude mouse model.

  2017cites this paper
• Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria.

  2017cites this paper
• Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer

  2017cites this paper
• Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis*

  2017cites this paper
• Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.

  2017cites this paper
• Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D‐LC‐MS/MS

  2017cites this paper
• Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.

  2016cites this paper
• The E-box-like sterol regulatory element mediates the insulin-stimulated expression of hepatic clusterin.

  2015cites this paper
• Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study

  2015cites this paper
• Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy

  2015cites this paper
• Comparison of two FFPE preparation methods using label-free shotgun proteomics: Application to tissues of diverticulitis patients.

  2015cites this paper
• Rectal Effluent as a Research Tool

  2014cites this paper
• Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer

  2014cites this paper
• Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics

  2014cites this paper
• Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review.

  2014cites this paper
• An investigation into tetraspanin CD151 as novel prognostic markers in poor outcome endometrial cancer

  2014cites this paper
• New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA

  2014cites this paper
• Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions

  2013cites this paper
• Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions

  2013cites this paper
• Chapter 2 Molecular screening to colorectal cancer Adapted from : Molecular tests for colorectal cancer screening

  2013cites this paper
• Analysis of acute‐phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer

  2012cites this paper
• Secreted Clusterin in Colon Tumor Cell Models and Its Potentialas Diagnostic Marker for Colorectal Cancer

  2012cites this paper
• Colorectal cancer screening: are stool and blood based tests good enough?

  2012cites this paper
• XRCC5 (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand- break rejoining))

  2012cites this paper
• A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection

  2011cites this paper
• SREBP-1c regulates glucose-stimulated hepatic clusterin expression.

  2011cites this paper
• Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps

  2011cites this paper
• Fem1b antigen in the stool of ApcMin mice as a biomarker of early Wnt signaling activation in intestinal neoplasia.

  2011cites this paper
• Molecular tests for colorectal cancer screening.

  2011cites this paper
• MicroRNA Dysregulation in Colon Cancer Microenvironment Interactions: The Importance of Small Things in Metastases

  2011cites this paper
• XRCC6 (X-ray repair complementing defective repair in Chinese hamster cells 6)

  2011cites this paper
• Serum Tests for Colorectal Cancer Screening

  2011cites this paper
• Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk?

  2011cites this paper
• CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.

  2009influential citation
• Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.

  2009cites this paper